CN Patent
CN107109410B — 通道调节剂
Assigned to Onex Medical Co ltd · Expires 2021-11-02 · 5y expired
What this patent protects
本发明涉及包含连接蛋白调节剂、泛连接蛋白调节剂、间隙连接调节剂、半通道调节剂和泛连接蛋白通道调节剂的组合物和制造物品,以及它们单独或组合用于治疗眼部和其他病症的用途。
USPTO Abstract
本发明涉及包含连接蛋白调节剂、泛连接蛋白调节剂、间隙连接调节剂、半通道调节剂和泛连接蛋白通道调节剂的组合物和制造物品,以及它们单独或组合用于治疗眼部和其他病症的用途。
Drugs covered by this patent
- Xalatan (LATANOPROST) · Thea Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.